Identifying Subclinical Transthyretin Cardiac Amyloidosis in V142I TTR Carriers: Design, Rationale, and Methods of the VISTA (Variant Imaging of Subclinical Transthyretin Amyloidosis) Study | Synapse
March 3, 2026
Identifying Subclinical Transthyretin Cardiac Amyloidosis in V142I TTR Carriers: Design, Rationale, and Methods of the VISTA (Variant Imaging of Subclinical Transthyretin Amyloidosis) Study
Key Points
Subclinical cardiac amyloidosis was identified in V142I TTR carriers, indicating the need for earlier diagnosis strategies.
The study examines imaging techniques to detect transthyretin amyloidosis with a focus on V142I variant carriers.
Assessment utilizes advanced imaging methods to highlight biomarkers indicative of cardiac amyloidosis.
Findings underscore the importance of early intervention, although further validation in larger populations is necessary.